Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 70/100

Failure Rate

33.3%

1 terminated/withdrawn out of 3 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

33%

1 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 3
1(50.0%)
N/A
1(50.0%)
2Total
Phase 3(1)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT03941886Not ApplicableCompleted

Implementation of First-trimester Screening and preventiOn of pREeClAmpSia Trial (FORECAST)

Role: lead

NCT03540225Phase 3Withdrawn

Vaginal Progesterone for the Prevention of Preterm Birth in Twins

Role: lead

NCT03554681Completed

Prediction of Preeclampsia (PE) at 11-13 Week

Role: lead

All 3 trials loaded